Recruiting studies: Pulmonary Hypoplasia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Personalized First-line Chemotherapy Choice in Advanced Pancreatic Adenocarcinoma Using Transcriptomic Signatures
NA · 7 location(s) · Institut Curie · NCT05475366 A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
Phase 1/Phase 2 · 1 location(s) · Blueprint Medicines Corporation · NCT07629960 Amnioinfusion for Fetal Renal Failure
NA · 1 location(s) · Fetal Care Center, PLLC · NCT06728228 Serial Amnioinfusions as Regenerative Therapy for Pulmonary Hypoplasia
Phase 1 · 1 location(s) · Mayo Clinic · NCT03723564 Phase 2 Study for the Patient, Who Has Diagnosed With Small Cell Lung Cancer (SCLC) or Non Small Cell Lung Cancer (NSCLC
Phase 2 · 7 location(s) · Advenchen Pharmaceuticals, LLC. · NCT05363280 Study to Assess Safety, Tolerability and Activity of DSB2455 in Participants With Advanced Malignancies
Phase 1 · 18 location(s) · Duke Street Bio Ltd · NCT06458712 CHemotherapy and Stool Transplant in PDAC (CHASe-PDAC)
Phase 1 · 1 location(s) · John Lenehan · NCT06393400 A Phase II Clinical Study of SKB571 as Monotherapy in Patients With Locally Advanced or Metastatic Non-Small Cell Lung C
Phase 2 · 1 location(s) · Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. · NCT07308106 A Study of Sotorasib in People With Non-Small Cell Lung Cancer
Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT06582771 BBO-11818 in Adult Subjects With KRAS Mutant Cancer
Phase 1 · 17 location(s) · TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics) · NCT06917079 Safety and Efficacy of FETO in CDH: A Phase III Trial
NA · 1 location(s) · Holly L Hedrick, MD · NCT06884423 Safety and Efficacy of FETO in CDH Phase III
Phase 3 · 1 location(s) · Children's Hospital Medical Center, Cincinnati · NCT07187206 Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck
Phase 1 · 48 location(s) · AbbVie · NCT05005403 Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia (FETO)
NA · 2 location(s) · Rodrigo Ruano · NCT03138863 Durvalumab and Ablative Radiation in Small Cell Lung Cancer (DARES)
Phase 2 · 2 location(s) · University of Chicago · NCT05068232 Feto-Endoscopic Tracheal Occlusion (FETO) for Severe Congenital Diaphragmatic Hernia
NA · 1 location(s) · Children's Hospital Medical Center, Cincinnati · NCT02986087 Teniposide, Cisplatin and Serplulimab for Treatment of ES-SCLC, a Randomized Controlled Study
Phase 2 · 1 location(s) · Sun Yat-sen University · NCT07583511

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.